Alnylam Pharmaceuticals
ALNY
#453
Rank
โ‚ฌ44.11 B
Marketcap
333,91ย โ‚ฌ
Share price
-4.96%
Change (1 day)
38.04%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company